Answers are grounded in this paper and cite their sources.
Evaluates Bacillus velezensis S141's effectiveness in controlling chili pathogens and enhancing plant growth, indicating potential for integrated pest management.
Bacillus velezensis S141 was evaluated as a biocontrol agent against two economically important chili pathogens: Colletotrichum gloeosporioides and Fusarium oxysporum. The evaluations included in vitro , molecular, and in vivo approaches. Dual-culture and cell-free culture filtrate assays demonstrated that both direct bacterial contact and secreted metabolites suppressed mycelial growth and spore germination in a species-specific and concentration-dependent manner, with maximum mycelial inhibition of 51.75% for C. gloeosporioides and 44.02% for F. oxysporum . Scanning electron microscopy of the treated fungi revealed marked surface deformation and hyphal collapse consistent with cell-wall damage. Interestingly, in liquid co-culture, S141 suppressed early mycelial growth in both fungal species. However, F. oxysporum recovered and resumed spore production, indicating tolerance of sublethal metabolite concentrations, whereas C. gloeosporioides remained completely suppressed. Gene-expression analysis showed pathogen-responsive upregulation of biosynthetic genes encoding cell-wall-degrading enzymes during fungal co-culture. These findings provide direct transcriptional evidence consistent with activation of lipopeptide and hydrolytic-enzyme biosynthetic pathways. In vivo bioassays confirmed that S141 significantly reduced anthracnose severity on chili fruits regardless of ripeness stage, achieving reductions of 66–79% and suppression of both anthracnose and Fusarium wilt in seedlings. Furthermore, S141 promoted the chili seedlings growth by 28% through direct inoculation and by 45% through the emission of volatile organic compounds (VOCs). The results show that B. velezensis S141 a promising candidate for the integrated management of chili anthracnose and Fusarium wilt while concurrently promoting plant growth.
No takes yet. Share an insight, caveat, or question.
Songsaeng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: